🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression

RecruitingPhase 4Ages 18 Years - 65 YearsAllAalborg University Hospital
NCT07080723 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The trial utilizes a pragmatic, randomized, open label design with two parallel arms. Participants aged 18-65 with a diagnosis of unipolar depressive disorder and without stable remission in the past 12 months are randomized 1:1 to receive either algorithm guided treatment (AGT) or treatment as usual (TAU). The AGT approach incorporates pre-defined treatment steps, critical decision points, and "if-then" rules based on symptom response. It leverages prior treatment history, current symptomatology, and tolerability profiles to personalize the therapeutic sequence and reduce treatment inertia. In contrast, TAU reflects standard clinical practice, where treatment decisions are left to clinician discretion without algorithmic structure. The primary objective of the study is to determine whether AGT leads to a greater reduction in depressive symptoms over a 12-week treatment period, as measur

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. A diagnosis of unipolar depressive disorder according to ICD-10 based on documented completion of the Mini International Neuropsychiatric Interview, version 7.0.2 (MINI 7.0.2) at Screening and confirmed by medical records or a healthcare professional. 2. Have not achieved stable remission of depression in 12 months at investigator's clinical assessment. 3. Severity of depression: A score of at least 21 on the self-reported Major Depression Inventory (MDI). 4. Age criteria: Subjects must be at least 18 years old and below 65 at the time of randomization. 5. Signed document of informed consent. 6. The participant is an outpatient. 7. No significant change in medical treatment in the last 4 weeks before screening visit. 8. The patient is pharmacologically treated for depression. Exclusion Criteria: 1. A diagnosis of dementia. 2. Substance misuse influencing study participation as judged by the investigator. 3. High risk of non-adherence at the investigator's discretion. 4. Not understanding the Danish language as judged by the investigator. 5. Suicidality according to C-SSRS with a positive response to question 4 or 5 within the last three months or upon investigator's discretion. 6. Medical conditions such as cancer, kidney failure, epilepsy, deep brain stimulation device, or other medical conditions interfering with study the outcome and safety as judged by investigator's discretion.
💊

What it tests

  • Algorithm guided treatment (AGT)
  • Treatment as usual (TAU)
📍

Where

1 site
Aalborg University Hospital
Aalborg, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy